| Entry |
|
|---|
| Name |
Oblimersen (INN) |
|---|
| Formula |
C172H221N62O91P17S17
|
|---|
| Exact mass |
5680.5363
|
|---|
| Mol weight |
5684.66
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic, Translation inhibitor, Bcl-2 inhibitor |
|---|
| Type |
Antisense oligonucleotide |
|---|
| Comment |
Cytostatic, cytostaticum
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX36 Oblimersen
D08290 Oblimersen (INN)
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Cellular process
Apoptosis
BCL2
D08290 Oblimersen (INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
